Sjögren's disease trials in India

1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  Where

  Belagavi, Jaipur, Kochi, Nashik

  Age

  18 years and over

  People

  570 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07621809 · EU 2025-522271-29-00